What does this research mean for the field?

Biodegradable-polymer drug-eluting stents and contemporary durable-polymer drug-eluting stents demonstrate comparable long-term safety and efficacy in patients with acute coronary syndrome, with no significant differences in major adverse cardiovascular events. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To assess whether biodegradable-polymer drug-eluting stents provide superior safety and efficacy compared with second-generation durable-polymer drug-eluting stents in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

August 30, 2026Cardiology in Review

Comparative Safety and Efficacy of Biodegradable and Durable Polymer Drug-Eluting Stents in Patients with Acute Coronary Syndrome: A Systematic Review and Updated Meta-Analysis

View Full Paper

Ask AI

Bookmark

To assess whether biodegradable-polymer drug-eluting stents provide superior safety and efficacy compared with second-generation durable-polymer drug-eluting stents in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Systematic review and random-effects meta-analysis of PubMed, Cochrane, and ClinicalTrials.gov through September 2025.
Identified 10 randomized controlled trials (11 publications, N=10,130) with follow-up durations ranging from 6 months to 5 years.
Pooled risk ratios with 95% confidence intervals evaluating major adverse cardiovascular events as the primary outcome, alongside secondary clinical endpoints.
Major adverse cardiovascular events did not differ significantly between biodegradable-polymer and durable-polymer drug-eluting stent groups (RR 0.93, 95% CI 0.70–1.24).
No statistically significant differences occurred for all-cause or cardiac death, target-vessel myocardial infarction, stent thrombosis, target vessel or lesion revascularization, target lesion failure, or stroke, displaying low-to-no heterogeneity across most endpoints.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Meta-analysis finds equivalent safety and efficacy between biodegradable and durable polymer stents in acute coronary syndrome, suggesting no clinical advantage for dissolving polymers.

Cite This Study

Aslam et al. (2026) studied this question.

synapsesocial.com/papers/6a93f0c06c1a8fb52e79d22c https://doi.org/10.1097/crd.0000000000001439

View Full Paper

Ask AI

Bookmark

Implication

Meta-analysis finds equivalent safety and efficacy between biodegradable and durable polymer stents in acute coronary syndrome, suggesting no clinical advantage for dissolving polymers.

Comparative Safety and Efficacy of Biodegradable and Durable Polymer Drug-Eluting Stents in Patients with Acute Coronary Syndrome: A Systematic Review and Updated Meta-Analysis

Key Points

Discussion

Implication

Cite This Study

Comparative Safety and Efficacy of Biodegradable and Durable Polymer Drug-Eluting Stents in Patients with Acute Coronary Syndrome: A Systematic Review and Updated Meta-Analysis

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider